Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)
HKD 14.0
(-0.99%)
HKD 14.0
(-0.99%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 35.1 Billion CNY | 16.07% |
| 2022 | 30.24 Billion CNY | 24.76% |
| 2021 | 24.24 Billion CNY | 0.96% |
| 2020 | 24.01 Billion CNY | 9.62% |
| 2019 | 21.9 Billion CNY | -5.6% |
| 2018 | 23.2 Billion CNY | 14.36% |
| 2017 | 20.29 Billion CNY | 80.84% |
| 2016 | 11.22 Billion CNY | 2.89% |
| 2015 | 10.9 Billion CNY | 39.68% |
| 2014 | 7.8 Billion CNY | 38.83% |
| 2013 | 5.62 Billion CNY | 9.09% |
| 2012 | 5.15 Billion CNY | -15.51% |
| 2011 | 6.1 Billion CNY | 32.98% |
| 2010 | 4.58 Billion CNY | 60.02% |
| 2009 | 2.86 Billion CNY | 70.39% |
| 2008 | 1.68 Billion CNY | -26.93% |
| 2007 | 2.3 Billion CNY | 14.57% |
| 2006 | 2.01 Billion CNY | 13.73% |
| 2005 | 1.76 Billion CNY | 23.19% |
| 2004 | 1.43 Billion CNY | -3.91% |
| 2003 | 1.49 Billion CNY | 82.53% |
| 2002 | 818.08 Million CNY | 25.35% |
| 2001 | 652.65 Million CNY | 321.42% |
| 2000 | 154.87 Million CNY | 291.09% |
| 1999 | 39.6 Million CNY | 31.58% |
| 1998 | 30.09 Million CNY | 33.76% |
| 1997 | 22.5 Million CNY | -23.73% |
| 1996 | 29.5 Million CNY | -16.55% |
| 1995 | 35.35 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 34.9 Billion CNY | -0.59% |
| 2024 Q3 | 27.54 Billion CNY | -14.44% |
| 2024 Q2 | 34.79 Billion CNY | -0.32% |
| 2023 Q1 | 30.78 Billion CNY | 1.76% |
| 2023 Q2 | 33.71 Billion CNY | 9.55% |
| 2023 Q3 | 33.37 Billion CNY | -1.0% |
| 2023 Q4 | 35.1 Billion CNY | 5.18% |
| 2023 FY | 35.1 Billion CNY | 16.07% |
| 2022 Q1 | 26.71 Billion CNY | 10.17% |
| 2022 FY | 30.24 Billion CNY | 24.76% |
| 2022 Q4 | 30.24 Billion CNY | 0.38% |
| 2022 Q3 | 30.13 Billion CNY | 0.48% |
| 2022 Q2 | 29.98 Billion CNY | 12.27% |
| 2021 Q3 | 24.01 Billion CNY | 0.26% |
| 2021 Q4 | 24.24 Billion CNY | 0.97% |
| 2021 FY | 24.24 Billion CNY | 0.96% |
| 2021 Q1 | 23.89 Billion CNY | -0.51% |
| 2021 Q2 | 23.95 Billion CNY | 0.24% |
| 2020 Q1 | 22.93 Billion CNY | 4.7% |
| 2020 FY | 24.01 Billion CNY | 9.62% |
| 2020 Q2 | 23.14 Billion CNY | 0.89% |
| 2020 Q3 | 24.92 Billion CNY | 7.71% |
| 2020 Q4 | 24.01 Billion CNY | -3.65% |
| 2019 FY | 21.9 Billion CNY | -5.6% |
| 2019 Q1 | 23.77 Billion CNY | 2.46% |
| 2019 Q2 | 23.25 Billion CNY | -2.2% |
| 2019 Q3 | 24.55 Billion CNY | 5.56% |
| 2019 Q4 | 21.9 Billion CNY | -10.77% |
| 2018 Q3 | 23.25 Billion CNY | 0.69% |
| 2018 FY | 23.2 Billion CNY | 14.36% |
| 2018 Q2 | 23.09 Billion CNY | 7.47% |
| 2018 Q4 | 23.2 Billion CNY | -0.21% |
| 2018 Q1 | 21.48 Billion CNY | 5.9% |
| 2017 Q4 | 20.29 Billion CNY | 1.47% |
| 2017 FY | 20.29 Billion CNY | 80.84% |
| 2017 Q3 | 19.99 Billion CNY | 30.03% |
| 2017 Q2 | 15.38 Billion CNY | 10.33% |
| 2017 Q1 | 13.94 Billion CNY | 24.23% |
| 2016 Q2 | 11.96 Billion CNY | 0.38% |
| 2016 Q4 | 11.22 Billion CNY | -7.6% |
| 2016 FY | 11.22 Billion CNY | 2.89% |
| 2016 Q3 | 12.14 Billion CNY | 1.53% |
| 2016 Q1 | 11.91 Billion CNY | 9.27% |
| 2015 Q4 | 10.9 Billion CNY | 0.58% |
| 2015 Q2 | 8.08 Billion CNY | 3.4% |
| 2015 FY | 10.9 Billion CNY | 39.68% |
| 2015 Q3 | 10.84 Billion CNY | 34.14% |
| 2015 Q1 | 7.81 Billion CNY | 0.13% |
| 2014 Q2 | 6.8 Billion CNY | 4.74% |
| 2014 Q1 | 6.49 Billion CNY | 15.49% |
| 2014 Q4 | 7.8 Billion CNY | -8.12% |
| 2014 FY | 7.8 Billion CNY | 38.83% |
| 2014 Q3 | 8.49 Billion CNY | 24.91% |
| 2013 FY | 5.62 Billion CNY | 9.09% |
| 2013 Q4 | 5.62 Billion CNY | -2.32% |
| 2013 Q3 | 5.75 Billion CNY | -4.75% |
| 2013 Q2 | 6.04 Billion CNY | 17.42% |
| 2013 Q1 | 5.14 Billion CNY | -0.15% |
| 2012 Q4 | 5.15 Billion CNY | -14.36% |
| 2012 FY | 5.15 Billion CNY | -15.51% |
| 2012 Q1 | 6.4 Billion CNY | 4.91% |
| 2012 Q2 | 6.14 Billion CNY | -4.03% |
| 2012 Q3 | 6.02 Billion CNY | -2.01% |
| 2011 Q4 | 6.1 Billion CNY | 3.4% |
| 2011 Q1 | 7.01 Billion CNY | 52.97% |
| 2011 Q2 | 5.97 Billion CNY | -14.94% |
| 2011 FY | 6.1 Billion CNY | 32.98% |
| 2011 Q3 | 5.9 Billion CNY | -1.16% |
| 2010 FY | 4.58 Billion CNY | 60.02% |
| 2010 Q1 | 3.15 Billion CNY | 9.92% |
| 2010 Q3 | 3.79 Billion CNY | 20.49% |
| 2010 Q4 | 4.58 Billion CNY | 21.03% |
| 2010 Q2 | 3.14 Billion CNY | -0.18% |
| 2009 Q1 | 2.18 Billion CNY | 29.77% |
| 2009 Q4 | 2.86 Billion CNY | -0.68% |
| 2009 Q3 | 2.88 Billion CNY | -2.01% |
| 2009 FY | 2.86 Billion CNY | 70.39% |
| 2009 Q2 | 2.94 Billion CNY | 34.92% |
| 2008 Q3 | 1.97 Billion CNY | -1.49% |
| 2008 Q4 | 1.68 Billion CNY | -14.64% |
| 2008 Q1 | 2.2 Billion CNY | -4.41% |
| 2008 FY | 1.68 Billion CNY | -26.93% |
| 2008 Q2 | 2 Billion CNY | -9.09% |
| 2007 Q3 | 2.07 Billion CNY | -4.83% |
| 2007 Q2 | 2.18 Billion CNY | 6.89% |
| 2007 FY | 2.3 Billion CNY | 14.57% |
| 2007 Q1 | 2.04 Billion CNY | 1.51% |
| 2007 Q4 | 2.3 Billion CNY | 10.95% |
| 2006 Q2 | 1.85 Billion CNY | 5.43% |
| 2006 Q4 | 2.01 Billion CNY | 5.12% |
| 2006 Q3 | 1.91 Billion CNY | 3.18% |
| 2006 Q1 | 1.75 Billion CNY | -0.55% |
| 2006 FY | 2.01 Billion CNY | 13.73% |
| 2005 Q3 | 1.8 Billion CNY | 5.49% |
| 2005 Q4 | 1.76 Billion CNY | -2.17% |
| 2005 Q1 | 1.64 Billion CNY | 14.91% |
| 2005 Q2 | 1.71 Billion CNY | 3.88% |
| 2005 FY | 1.76 Billion CNY | 23.19% |
| 2004 Q3 | 1.41 Billion CNY | -0.19% |
| 2004 Q1 | 1.25 Billion CNY | -16.19% |
| 2004 Q2 | 1.41 Billion CNY | 12.95% |
| 2004 FY | 1.43 Billion CNY | -3.91% |
| 2004 Q4 | 1.43 Billion CNY | 1.7% |
| 2003 Q3 | 866.72 Million CNY | -4.81% |
| 2003 Q1 | 808.27 Million CNY | -1.2% |
| 2003 Q4 | 1.49 Billion CNY | 72.28% |
| 2003 Q2 | 910.51 Million CNY | 12.65% |
| 2003 FY | 1.49 Billion CNY | 82.53% |
| 2002 Q1 | 889.15 Million CNY | 36.24% |
| 2002 FY | 818.08 Million CNY | 25.35% |
| 2002 Q3 | 836.54 Million CNY | -19.99% |
| 2002 Q2 | 1.04 Billion CNY | 17.59% |
| 2002 Q4 | 818.08 Million CNY | -2.21% |
| 2001 Q4 | 652.65 Million CNY | 0.0% |
| 2001 FY | 652.65 Million CNY | 321.42% |
| 2001 Q2 | 296.45 Million CNY | 0.0% |
| 2000 FY | 154.87 Million CNY | 291.09% |
| 2000 Q2 | 271.64 Million CNY | 0.0% |
| 2000 Q4 | 154.87 Million CNY | 0.0% |
| 1999 Q2 | 55.59 Million CNY | 0.0% |
| 1999 Q4 | 39.6 Million CNY | 0.0% |
| 1999 FY | 39.6 Million CNY | 31.58% |
| 1998 FY | 30.09 Million CNY | 33.76% |
| 1998 Q4 | 30.09 Million CNY | 0.0% |
| 1998 Q2 | 5 Million CNY | 0.0% |
| 1997 FY | 22.5 Million CNY | -23.73% |
| 1996 FY | 29.5 Million CNY | -16.55% |
| 1995 FY | 35.35 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 6.8 Million HKD | -515459.016% |
| Grand Pharmaceutical Group Limited | 3.4 Billion HKD | -931.348% |
| Extrawell Pharmaceutical Holdings Limited | 120.41 Million HKD | -29058.346% |
| Wai Yuen Tong Medicine Holdings Limited | 460.94 Million HKD | -7516.8% |
| Qianhai Health Holdings Limited | 487 Thousand HKD | -7209256.024% |
| Lee's Pharmaceutical Holdings Limited | 204.14 Million HKD | -17098.767% |
| Essex Bio-Technology Limited | 294.02 Million HKD | -11841.126% |
| Tongfang Kontafarma Holdings Limited | 333.82 Million HKD | -10417.419% |
| PuraPharm Corporation Limited | 424.77 Million HKD | -8165.547% |
| SSY Group Limited | 3.37 Billion HKD | -940.565% |
| JBM (Healthcare) Limited | 133.4 Million HKD | -26217.632% |
| Jacobson Pharma Corporation Limited | 749.37 Million HKD | -4585.154% |
| China Resources Pharmaceutical Group Limited | 85.84 Billion HKD | 59.102% |